Trials / Recruiting
RecruitingNCT06105411
Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Peter MacCallum Cancer Centre, Australia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.
Detailed description
This open label, single centre, proof of concept pilot imaging trial will evaluate technique for the diagnosis of invasive Aspergillus infection. It aims to demonstrate uptake of the gallium-siderophore tracer at sites of known proven/probable invasive aspergillus app infection. It will also assess the safety and tolerability of this technique. 10 patients within 2 weeks of proven or probable invasive fungal infection (IFI) diagnosis will be recruited to this study over a period of 12-24 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 68Ga-labelled TAFC PET/CT scan | 68Ga-labelled TAFC PET/CT scan (whole body) |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2026-10-01
- Completion
- 2027-04-01
- First posted
- 2023-10-27
- Last updated
- 2025-09-05
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06105411. Inclusion in this directory is not an endorsement.